ArticleGenes & diseases2026

Targeting fatty acid synthase to overcome PARP inhibitor resistance and to create an artificial synthetic lethality for triple-negative breast cancer.

Sophia Josephraj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.